Event on Sept. 11 in Washington D.C. will feature the latest information on using GLP-1s to tackle the obesity epidemic.

Prime Therapeutics researchers shared real-world insights at AMCP Nexus 2025 on GLP-1 utilization, treatment persistence and strategies to improve access to these high-demand therapies

PUBLICATIONS FDA Decisions Expected: August 2025 Your monthly synopsis of new drugs expected to hit the market All brand names are property of their respective owners. References Press release:...

Real-world, integrated data follows-up on previous insights, analytics.